Related Experiment Video
Updated: Jun 11, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
Junshang Ge1,2,3, Yi Meng1,2,3, Jiayue Guo1,2,3
1Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
Immune evasion represents a crucial milestone in the progression of cancer and serves as the theoretical foundation for tumor immunotherapy. In this study, we reveal a negative association between Human Papillomavirus (HPV)-encoded circular RNA, circE7, and the infiltration of CD8+ T cells in head and neck squamous cell carcinoma (HNSCC). Both in vitro and in vivo experiments demonstrate that circE7 suppresses the function and activity of T cells by downregulating the transcription of LGALS9, which encodes the galectin-9 protein. The molecular mechanism involves circE7 binding to acetyl-CoA carboxylase 1 (ACC1), promoting its dephosphorylation and thereby activating ACC1. Activated ACC1 reduces H3K27 acetylation at the LGALS9 gene promoter, leading to decreased galectin-9 expression. Notably, galectin-9 interacts with immune checkpoint molecules TIM-3 and PD-1, inhibiting the secretion of cytotoxic cytokines by T cells and promoting T cell apoptosis. Here, we demonstrate a mechanism by which HPV promotes immune evasion in HNSCC through a circE7-driven epigenetic modification and propose a potential immunotherapy strategy for HNSCC that involves the combined use of anti-PD-1 and anti-TIM-3 inhibitors.
Insights
Human Papillomavirus (HPV) circE7 RNA hinders anti-tumor immunity in head and neck cancer by reducing CD8+ T cell activity. This suggests combined PD-1 and TIM-3 inhibition as a potential HNSCC immunotherapy.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Immune evasion is critical in cancer progression and a target for immunotherapy.
- Human Papillomavirus (HPV) is implicated in head and neck squamous cell carcinoma (HNSCC).
Purpose of the Study:
- To investigate the role of HPV-encoded circE7 in HNSCC immune evasion.
- To elucidate the molecular mechanism by which circE7 affects T cell activity and explore potential immunotherapeutic strategies.
Main Methods:
- In vitro and in vivo experiments were conducted.
- Assessed the association between circE7 and CD8+ T cell infiltration in HNSCC.
- Investigated the molecular pathway involving circE7, ACC1, LGALS9, galectin-9, TIM-3, and PD-1.
Main Results:
- A negative correlation was found between HPV circE7 and CD8+ T cell infiltration in HNSCC.
- circE7 suppresses T cell function by downregulating galectin-9 via epigenetic modification of the LGALS9 gene.
- Galectin-9 interacts with TIM-3 and PD-1, inhibiting T cell cytokine secretion and promoting apoptosis.
Conclusions:
- HPV circE7 promotes immune evasion in HNSCC through epigenetic regulation.
- Combined anti-PD-1 and anti-TIM-3 therapy is proposed as a potential immunotherapy for HNSCC.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Viruses with RNA Genomes
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia

